IBEX Limited — Form 10-Q Summary
Reporting period: Three months ended September 30, 2023, IBEX’s fiscal 2024 first quarter (the metadata labels this “2023 Q1”). Comparisons are with the three months ended September 30, 2022. IBEX provides technology-enabled customer experience and business-process outsourcing services and reported as a single operating segment. The company became a domestic filer and adopted U.S. GAAP reporting beginning July 1, 2023.
Financial performance and liquidity
| Metric | Quarter ended Sept. 30, 2023 | Prior-year quarter | Change |
|---|---|---|---|
| Revenue | $124.6 million | $127.8 million | Down 2.5% |
| Operating income / margin | $8.3 million / 6.7% | $7.7 million / 6.0% | Income up 8.6% |
| Net income / margin | $7.4 million / 6.0% | $6.5 million / 5.1% | Up 13.8% |
| Diluted EPS | $0.39 | $0.35 | Up 12.3% |
| Adjusted EBITDA / margin | $13.7 million / 11.0% | $12.9 million / 10.1% | Margin expanded |
| Operating cash flow | $8.7 million | $5.6 million | Increased |
| Free cash flow | $6.6 million | $2.0 million | Increased |
Cash and cash equivalents were $62.0 million at September 30, 2023, versus $57.4 million at June 30, 2023. Total debt was approximately $1.0 million, consisting of finance leases; there were no borrowings outstanding under the PNC revolving credit facility. The company reported $72.6 million of borrowing availability, subject to eligible collateral, and compliance with debt covenants. Management said existing cash, operating cash flow and credit availability should cover liquidity needs for at least the next 12 months.
Total assets were $295.5 million and total liabilities were $139.4 million at quarter-end. Operating lease liabilities totaled $74.1 million. Capital expenditures were $2.1 million. The current ratio was approximately 2.3, based on reported current assets and current liabilities.
Material changes and management commentary
- Revenue declined $3.2 million, primarily because FinTech revenue fell $7.0 million, or 27.5%, amid macroeconomic pressures. Growth in Retail and E-commerce ($1.9 million) and HealthTech ($1.8 million) partly offset the decline.
- Cost of services fell 8.3%, reflecting lower payroll and related costs, facilities and other expenses, including site optimization and a greater delivery mix in lower-cost regions. Payroll costs declined to 53.6% of revenue from 57.6%.
- SG&A rose 19.3%, mainly due to leadership, IT, legal and professional, and travel costs. Depreciation and amortization increased 7.8%.
- Management attributed margin improvement to stronger utilization and a shift toward nearshore and offshore delivery. It said clients’ cost-reduction efforts and relocation of work to lower-cost markets contributed to modest revenue pressure, while creating potential opportunities.
- One client represented 12% of revenue, compared with 14% a year earlier; the three largest clients represented 30% of revenue. Approximately 97% of revenue came from U.S.-based clients.
Outlook, risks and notable items
- The filing provides no specific numerical financial guidance. Management expected macroeconomic factors to affect operations in the near term and said sales activity could pick up during fiscal 2024; sales cycles had lengthened.
- IBEX described a three-pronged generative-AI strategy focused on agent productivity, customer insights and customer-facing voice and chat bots. Management views AI adoption as an opportunity, while identifying data security, governance, implementation and coordination challenges.
- Key risks include client retention and concentration, changing outsourcing demand, wage inflation and labor availability, capacity utilization, foreign-exchange exposure, cybersecurity and privacy, and international operations. A 10% currency movement could materially affect reported local-currency costs; the filing estimates the quarterly expense sensitivity at about $2.8 million for the Philippine peso, $1.4 million for the Jamaican dollar and $0.9 million for the Pakistani rupee in the appreciation case.
- The company had $34.3 million in Philippine-peso currency collars; their quarter-end fair value was a $0.3 million liability. The interest-rate swap expired in March 2023 and was not replaced.
- On September 18, IBEX authorized repurchases of up to $30 million over six months. It repurchased 134,524 shares for approximately $2.0 million during the quarter; approximately $28.0 million remained authorized at September 30. Through November 8, it had repurchased 419,136 shares, with approximately $23.3 million remaining.
- Disclosure controls and procedures were deemed ineffective because a material weakness involving complex, non-routine transactions remained unremediated. Management said remediation was ongoing. The filing reported ordinary-course claims and lawsuits but no specific material proceeding; management could not assure that claims would have no material adverse effect.
Important facts for investors to verify
- Whether the FinTech revenue decline stabilizes and growth in HealthTech and Retail and E-commerce continues.
- Whether the offshore and nearshore mix shift produces durable margin gains without weakening service quality or client retention.
- Progress on AI deployment, including implementation costs, client adoption and data-security controls.
- Completion and demonstrated effectiveness of the material-weakness remediation plan.
- Cash generation, use of the remaining repurchase authorization, and actual availability under the collateral-based credit facility.
- Exposure to wage and foreign-exchange movements, including the extent to which pricing adjustments and hedges offset these costs.